Impact of pregnancy on prognosis of differentiated thyroid cancer: clinical and molecular features

Papillary Thyroid Cancer: Time Course of Recurrences During Postsurgery Surveillance

(2013) Cosimo Durante et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient's risk

(2012) Flavia Magri et al.   ENDOCRINE-RELATED CANCER

The Utility of Serum Thyroglobulin Measurement at the Time of Remnant Ablation for Predicting Disease-Free Status in Patients with Differentiated Thyroid Cancer: A Meta-Analysis Involving 3947 Patients

(2012) Richard C. Webb et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer

(2011) Tae Hyuk Kim et al.   CANCER

Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum

(2011) Alex Stagnaro-Green et al.   THYROID

Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy

(2009) Guia Vannucchi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

RAS Mutations Are the Predominant Molecular Alteration in Poorly Differentiated Thyroid Carcinomas and Bear Prognostic Impact

(2009) Marco Volante et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM